A new study, published in the Journal of the American Geriatrics Society, examines whether people who took proton pump inhibitors were at higher risk for Alzheimer's disease and dementia.
For the study, researchers examined people, aged 50 years and older at up to six visits. They studied 884 who were taking PPIs at every patient visit; 1,925 who took PPIs intermittently; and 7,677 never reported taking PPIs. The study participants either had normal cognition or mild cognitive impairment.
The study shows continuous or intermittent PPI use was linked to a decreased risk of decline in cognitive function as well as lower risk of developing Alzheimer's disease.
"Proton pump inhibitors were not associated with greater risk of dementia or of AD, in contrast to recent reports," the study authors conclude.
More articles on infection control:
Hudson Headwaters Health Network employee diagnosed with measles
3 things to know about the next zoonotic pandemic
A new warrior in the sepsis fight: Dedicated sepsis nurses